A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With Placebo

Completed · Phase 3 · Has a placebo group

Conditions studied: Benign Prostatic Hyperplasia

In brief

A new drug for benign prostatic hyperplasia is compared to placebo for to determine if it is safe and effective. The study lasts approximately 20 weeks.

Key facts

Study ID

NCT00224120

Run by

Watson Pharmaceuticals

People needed

462

Starts

2005-05-01

Expected to finish

2006-05-01

Last updated by the study team

2009-12-15

Who can join

Age: 50 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Males in good general health and at least 50 years of age, with symptoms of moderate to severe BPH.

You may not qualify if…

• Medical conditions that would confound the efficacy evaluation.
• Medical conditions in which it would be unsafe to use an alpha-blocker.
• The use of concomitant drugs that would confound the efficacy evaluation.
• The use of concomitant drugs that would be unsafe with this alpha-blocker.

Where it is running

• Study site — Birmingham, Alabama, United States
• Study site — Carmichael, California, United States
• Study site — Fresno, California, United States
• Study site — Laguna Woods, California, United States
• Study site — San Bernardino, California, United States
• Study site — Tarzana, California, United States
• Study site — Torrance, California, United States
• Study site — New Port Richey, Florida, United States
• Study site — Ocala, Florida, United States
• Study site — Orlando, Florida, United States
• Study site — Plantation, Florida, United States
• Study site — Tampa, Florida, United States
• Study site — West Palm Beach, Florida, United States
• Study site — Chicago, Illinois, United States
• Study site — Melrose Park, Illinois, United States
• Study site — Evansville, Indiana, United States
• Study site — Fort Wayne, Indiana, United States
• Study site — Overland Park, Kansas, United States
• Study site — Greenbelt, Maryland, United States
• Study site — Boston, Massachusetts, United States
• Study site — Jackson, Mississippi, United States
• Study site — Kansas City, Missouri, United States
• Study site — Lawrenceville, New Jersey, United States
• Study site — Voorhees Township, New Jersey, United States
• Study site — Albuquerque, New Mexico, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.